Former MedImmune execs raise $10 million for new start-up Zyngenia
09 November 2009
Sukaina Virji
Please Login to read the full article.
09 November 2009
Sukaina Virji
sukaina.virji@informa.com
A number of former MedImmune executives have launched a new biotechnology company called Zyngenia with $10 million in series A funding from New Enterprise Associates (NEA).
Zyngenia's chief executive officer
Peter Kiener, formerly executive vice-president for research at MedImmune, and chief...
Please Login to read the full article.
RELATED CONTENT
NEWS
- 7th Annual Scrip Awards: Novartis, Jimenez, Burrill, Glenmark, ICON win
- Omthera raises $34 million to take omega-3 fatty acid drug into Phase III
- Rare disease-focused Prosensa brings in US investor in new €23 million round
- TVAX Biomedical plans killer $40M IPO to fund PhIII vaccine for naive astrocytoma
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
